Star Sports Medicine Co., Ltd. (HKG:1609)
Hong Kong · Delayed Price · Currency is HKD 119.90
+6.90 (6.11%)
Jul 31, 2026, 4:08 PM HKT
Star Sports Medicine Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 136.97 | 95.39 | 57.11 | 40.34 | -110.25 |
Depreciation & Amortization | 14.85 | 13.94 | 12.87 | 4.62 | 3.18 |
Other Amortization | - | - | - | 2.54 | 1.43 |
Loss (Gain) From Sale of Assets | - | 0.01 | 0.03 | - | - |
Asset Writedown & Restructuring Costs | 1.64 | 0.11 | -0.01 | - | 0.03 |
Loss (Gain) From Sale of Investments | -2.66 | - | -0.08 | -1.45 | -1.17 |
Stock-Based Compensation | 1.21 | 1.08 | 0.91 | - | 116.08 |
Provision & Write-off of Bad Debts | - | - | - | 0.11 | -0.03 |
Other Operating Activities | 7.64 | 2.2 | 7.16 | -2.37 | 2.26 |
Change in Accounts Receivable | -23.49 | -16.6 | 0.61 | -5.5 | -0.22 |
Change in Inventory | -13.29 | -24.57 | -18.45 | 3.13 | -11.03 |
Change in Accounts Payable | 4.13 | 10.51 | 6.83 | 14.11 | 13.39 |
Change in Other Net Operating Assets | 30.13 | 12.44 | 12.88 | - | - |
Operating Cash Flow | 157.12 | 94.52 | 79.86 | 55.81 | 8 |
Operating Cash Flow Growth | 66.23% | 18.36% | 43.08% | 597.35% | - |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -34.24 | -27.16 | -17.47 | -8.52 | -3.14 |
Sale of Property, Plant & Equipment | - | - | 0 | - | - |
Sale (Purchase) of Intangibles | - | - | -3.78 | - | - |
Investment in Securities | -86.33 | -344.09 | 0.08 | 13 | 3 |
Other Investing Activities | - | - | - | 1.55 | 1.4 |
Investing Cash Flow | -120.56 | -371.25 | -21.17 | 6.03 | 1.26 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | 13.72 | 17 | - | - | - |
Long-Term Debt Repaid | -3.84 | -4.13 | -3.54 | - | - |
Net Debt Issued (Repaid) | 9.88 | 12.87 | -3.54 | - | - |
Issuance of Common Stock | - | - | 36.67 | 135.91 | 49.99 |
Other Financing Activities | -19.24 | -2.74 | -8.53 | -2.54 | -2.49 |
Financing Cash Flow | -9.35 | 10.13 | 24.59 | 133.36 | 47.5 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.32 | 0.2 | 0.25 | 3.37 | -0.17 |
Net Cash Flow | 26.88 | -266.4 | 83.53 | 198.57 | 56.58 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 122.88 | 67.36 | 62.39 | 47.29 | 4.86 |
Free Cash Flow Growth | 82.44% | 7.97% | 31.91% | 873.19% | - |
Free Cash Flow Margin | 30.51% | 20.59% | 26.15% | 31.96% | 6.66% |
Free Cash Flow Per Share | 2.65 | 1.45 | 1.34 | 0.76 | - |
Levered Free Cash Flow | 25.76 | 65.5 | 26.18 | 33.12 | 50.32 |
Unlevered Free Cash Flow | 26.3 | 65.76 | 26.48 | 33.46 | 50.58 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 13.62 | 12.19 | 1.49 | 11.28 | 2.46 |
Change in Working Capital | -2.53 | -18.22 | 1.88 | 12.02 | -3.52 |